Atlas Trials

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Clinical trial NCT04670445 · UNKNOWN

Trial details

NCT number
NCT04670445
Sponsor
Massachusetts General Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung CancerUnresectable Non-Small Cell Lung CarcinomaUnresectable Stage III Non-Small Cell Lung CancerSmall Cell Lung Cancer Extensive StageStage IV Merkel Cell CarcinomaStage IV Cutaneous Squamous Cell CarcinomaStage IV Basal Cell CarcinomaStage IV Breast CancerStage IV Colorectal CancerStage IV Gastric Cancer
Start date
2021-01-23
Primary completion
2023-03-23
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.